CompositionIPCA MMF-S Tablet is primarily used to prevent organ rejection in adults who have undergone kidney, heart, or liver transplant. This medication is part of a group of medicines known as immunosuppressants.
Not only does this medicine act as a safeguard against organ rejection post-transplant, but it also works in combination with other immunosuppressants like cyclosporine and corticosteroids. This combined action aims to improve the survival of both the patient and the newly transplanted organ. The tablet specifically targets and suppresses the immune system to prevent it from damaging the new organ.
Before you commence taking this medicine, consult your doctor who will guide you on the appropriate dosage and frequency. It's important to inform your doctor about any pre-existing conditions or ongoing medications you're on before starting this medication. If you observe any side effects while on this medicine, notify your doctor immediately. For the best results, ensure you continue taking the tablet for the duration prescribed by your doctor.
